000904417 001__ 904417
000904417 005__ 20220131120426.0
000904417 0247_ $$2doi$$a10.3389/fnins.2021.718335
000904417 0247_ $$2ISSN$$a1662-453X
000904417 0247_ $$2ISSN$$a1662-4548
000904417 0247_ $$2Handle$$a2128/30231
000904417 0247_ $$2altmetric$$aaltmetric:113381261
000904417 0247_ $$2pmid$$a34557067
000904417 0247_ $$2WOS$$aWOS:000697395000001
000904417 037__ $$aFZJ-2021-05987
000904417 082__ $$a610
000904417 1001_ $$0P:(DE-HGF)0$$aGuethlein, Nora$$b0$$eCorresponding author
000904417 245__ $$aHealthcare for Trans*gender People in Germany: Gaps, Challenges, and Perspectives
000904417 260__ $$aLausanne$$bFrontiers Research Foundation$$c2021
000904417 3367_ $$2DRIVER$$aarticle
000904417 3367_ $$2DataCite$$aOutput Types/Journal article
000904417 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1642096774_4885
000904417 3367_ $$2BibTeX$$aARTICLE
000904417 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000904417 3367_ $$00$$2EndNote$$aJournal Article
000904417 520__ $$aPeople whose gender does not correspond to the binary gender system, i.e., trans∗gender people, face two main problems when it comes to healthcare in Germany: (1) They often suffer from general psychiatric comorbidities as well as specific and significant mental distress due to gender dysphoria, and (2) the German healthcare system lacks sufficiently educated and clinically experienced medical personnel who are able to provide specialized healthcare. Aside from transition, it often is extremely difficult for trans∗gender people to get access to and be integrated into the medical system. Stigmatization and pathologization in treatment are widespread, as are long waiting times for specialized healthcare providers who are often only accessible to those trans∗gender people willing to travel long distances. Frequently, trans∗gender people face further difficulties and barriers after transition, as some healthcare professionals fail to provide suitable care (e.g., gynecological consultation for transmen). The ICD-11 German Modification (ICD-11-GM), which should be routinely used by 2022, implements a depathologization of trans∗gender people in the medical system. This paper compares the issues related to health and healthcare of trans∗gender people in Germany with those in other European countries. We review the care offered by specialized centers with regard to treatment of and support for trans∗gender people. We conclude with specific proposals that may contribute to establish an improved, up-to-date, gender-sensitive healthcare system.
000904417 536__ $$0G:(DE-HGF)POF4-5252$$a5252 - Brain Dysfunction and Plasticity (POF4-525)$$cPOF4-525$$fPOF IV$$x0
000904417 588__ $$aDataset connected to CrossRef, Journals: juser.fz-juelich.de
000904417 7001_ $$0P:(DE-HGF)0$$aGrahlow, Melina$$b1
000904417 7001_ $$0P:(DE-HGF)0$$aLewis, Carolin A.$$b2
000904417 7001_ $$0P:(DE-HGF)0$$aBork, Stephan$$b3
000904417 7001_ $$0P:(DE-Juel1)172840$$aHabel, Ute$$b4$$ufzj
000904417 7001_ $$0P:(DE-HGF)0$$aDerntl, Birgit$$b5
000904417 773__ $$0PERI:(DE-600)2411902-7$$a10.3389/fnins.2021.718335$$gVol. 15, p. 718335$$p718335$$tFrontiers in neuroscience$$v15$$x1662-453X$$y2021
000904417 8564_ $$uhttps://juser.fz-juelich.de/record/904417/files/fnins-15-718335.pdf$$yOpenAccess
000904417 909CO $$ooai:juser.fz-juelich.de:904417$$pdnbdelivery$$pdriver$$pVDB$$popen_access$$popenaire
000904417 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)172840$$aForschungszentrum Jülich$$b4$$kFZJ
000904417 9131_ $$0G:(DE-HGF)POF4-525$$1G:(DE-HGF)POF4-520$$2G:(DE-HGF)POF4-500$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$9G:(DE-HGF)POF4-5252$$aDE-HGF$$bKey Technologies$$lNatural, Artificial and Cognitive Information Processing$$vDecoding Brain Organization and Dysfunction$$x0
000904417 9141_ $$y2021
000904417 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2021-05-04
000904417 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-05-04
000904417 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2021-05-04
000904417 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2021-05-04
000904417 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
000904417 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000904417 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bFRONT NEUROSCI-SWITZ : 2019$$d2021-05-04
000904417 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2021-05-04
000904417 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2021-05-04
000904417 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2021-05-04
000904417 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2021-05-04
000904417 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2021-05-04
000904417 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2021-05-04
000904417 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-05-04
000904417 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Blind peer review$$d2021-05-04
000904417 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2021-05-04
000904417 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2021-05-04
000904417 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2021-05-04
000904417 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2021-05-04
000904417 9201_ $$0I:(DE-Juel1)INM-10-20170113$$kINM-10$$lJara-Institut Brain structure-function relationships$$x0
000904417 9801_ $$aFullTexts
000904417 980__ $$ajournal
000904417 980__ $$aVDB
000904417 980__ $$aUNRESTRICTED
000904417 980__ $$aI:(DE-Juel1)INM-10-20170113